Rallis India Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/8vnxer3ay7lji15dv9v6hwbl.pdf

Key Takeaways


Domestic Crop Care: Volume-Led Growth

Dr. Gyanendra Shukla: "I am going to focus on domestic branded business where I have to make sure my product is being used more by the same farmer and on the more crop acres. That's where our focus is because prices are variable."

Seeds: The Returns-Reduction Story

Dr. Gyanendra Shukla: "Our aim would be that, look, we come to respectable at least a high single digit or low double digit. It all depends on the portfolio, because every seed business is a product business, there is nothing called me too here, your product must perform, otherwise even if you give it free to the farmer he won't buy it."

Exports: Pricing Pressure and Structural Challenges

Dr. Gyanendra Shukla: "The easier option is that if we are not making, we get out of the product, right. I think we are not at that stage yet. Whatever we do, we have to make sure we have all the information, and we have considered all the options."

Contract Manufacturing: Early-Stage Building


Financial Health & Capital Allocation


Market Context & Outlook

Dr. Gyanendra Shukla: "I am not expecting any miracle to happen in this market. I think it's going to be a normal growth period. Prices will continue to remain subdued given the commodity prices and supply situation."
Dr. Gyanendra Shukla: "While the short-term margin would be under pressure, long-term prospects continue to remain good."

Guidance & Commitments

CommitmentSpecificsTimeline
Pendimethalin capacity expansionNew efficient technologies to be commercializedBy end of FY25
Domestic formulation portfolio rationalizationStreamlined portfolio approach, evaluating desirability of each saleExercise completes in a couple of months; effective from FY26
Seeds profitabilityMove to positive zone, then keep improving; seeds should not be a drag on company profitabilityNo date; "slowly inching towards that"
Seeds market shareReach high single-digit or low double-digit share in ₹10,000 crore addressable segment (from ~4%)No date; near-term gains from cotton and rice
CAPEXApproximately ₹100 croreFY25
Export capacityNo new capacities until contracts in hand and improved utilization of existing capacitiesOngoing policy
Acephate resolutionEvaluating all options including cost reengineering, B2C presence, or exit; wants clarity sooner rather than laterNo fixed timeline; "it takes time" due to global dynamics

Key Metrics

MetricQ2 FY25
Revenue₹928 cr, vs ₹832 cr in Q2 FY24
EBITDA₹166 cr, 24% higher than Q2 FY24 (₹133 cr)
Profit after tax₹98 cr, 210% higher than Q2 FY24 (₹82 cr)
Domestic crop care revenue growth11%, with 17% volume growth
Domestic crop care volume growth17%
Domestic crop care price degrowth (H1 FY25, formulation)-6%
Seeds revenue₹141 cr, 48% growth YoY
Seeds H1 FY25 volume growthlargely flattish; high single-digit growth from price and mix
Export revenue₹143 cr
Herbicide category growth25%
Crop nutrition growth29%
Metribuzin H1 FY25 volumehighest ever, surpassing full FY24 volume
Diggaz cotton brand revenuecrossed ₹50 cr
Cotton portfolio revenue (FY25 to date)touched ₹100 cr
Cash and liquid balance₹229 cr as of 30th September
CAPEX envisaged for the year~₹100 cr
Trade receivables₹852 cr, up from ₹773 cr YoY